Early Access — free while we kick the tires
EdgarHawk

WILKINS III JAMES R

Director

Director
8 filings analyzed · 1 company · Latest 2024-12-10

Companies

Company Buys Sells Direction
FIRST NATIONAL CORP /VA/ FXNC 12 0 Net buying

Activity

December 2024
low
Buy
4 shares
$62
Significance 4/10

Director James R. Wilkins III buys 4 shares of FXNC at $15.40 on 2024-06-04; stock now at $25.70, +50.7% in 90 days.

Director Wilkins purchased 4 shares at $15.40, a modest transaction representing only a +0.0% change to his 9,369-share position at FXNC. The stock has appreciated significantly since the purchase date, trading at $25.70 (+50.7% over 90 days) and now only 0.2% below its 52-week high. Wilkins' track record across all tickers shows 20 prior buys with a 100% win rate at the 90-day mark, and his five prior purchases at FXNC were all well-timed, with 90-day returns ranging from 14.0% to 24.3%. However, the minimal share count acquired (4 shares, $61.60 total value) and negligible impact on his holdings (-0.0%) suggest this was a routine, de minimis transaction rather than a material capital commitment. The strong subsequent price performance and established pattern of well-timed acquisitions at this ticker provide some corroboration of asset quality, but the transaction scale offers limited insight into director conviction.

July 2024
medium
Buy
532 shares
$7,982
Significance 4/10

Director James R. Wilkins III purchases 532 shares across 2 transactions at FXNC for $7,981.60 (blended avg $15.00)

Director Wilkins made 2 separate open-market purchases totaling 532 shares for $7,981.60 ($8.0K) at a blended average price of $15.00 on June 27–28, 2024. This follows a concentrated buying pattern at FXNC: 5 prior purchases between June 17–26, all within the past 10 days, bringing his post-transaction holdings to 299.3K shares. The current stock price of $15.19 is -30.2% from its 52-week high of $21.75 and down 6.1% over 90 days, indicating the director is accumulating in a declining market environment. However, his cross-ticker track record shows 20 prior buys across all tickers with no measurable outcomes yet on same-ticker trades, making it premature to draw conclusions about timing accuracy at FXNC specifically. The company's fundamentals—$2.5M quarterly revenue, $3.2M net income, +1.7% annual revenue growth, and a P/E of 10.62—remain stable despite the stock's recent weakness.

June 2024
low
Buy
388 shares
$5,801
Significance 4/10

Director James R. Wilkins III bought 388 shares of FXNC at $14.95 on 2024-06-26; stock now at $15.17, down 30.2% from 52-week high.

Director Wilkins purchased 388 shares at $14.95, adding a modest 0.1% to his existing 298.8K share position at FIRST NATIONAL CORP /VA/. The stock has declined 6.7% over 90 days and trades 30.2% below its 52-week high, suggesting the purchase occurred during a period of weakness. His same-ticker history shows 5 prior buys within the same June 2024 window, all with outcomes not yet measurable, indicating a pattern of recent accumulation. Fundamentally, the company reports a P/E of 10.61 and generated net income of $3.2M on quarterly revenue of $2.5M, with modest annual revenue growth of 1.7%.

medium
Buy
886 shares
$13,246
Significance 4/10

Director James R. Wilkins III bought 886 shares of FXNC at $14.95 on 2024-06-25, adding to a string of 5 buys in June alone.

Director Wilkins purchased 886 shares at $14.95, increasing holdings modestly by 0.3% to 298,429 shares. This transaction is part of an unusually concentrated buying pattern at this ticker—5 purchases within a 12-day window (June 14–26, 2024), all executed near the stock's current price level despite the stock trading 29.9% below its 52-week high of $21.75. The timing and frequency of these purchases warrant examination to determine whether they reflect scheduled trading under a 10b5-1 plan or discretionary investment decisions. The company trades at a P/E of 10.66 with modest annual revenue growth of 1.7%, and no FLAG information is provided to indicate the nature of this purchasing pattern.

low
Buy
800 shares
$12,120
Significance 3/10

Director James R Wilkins III bought 800 shares of FXNC at $15.15 on 2024-06-20 (total $12,120.00)

James R Wilkins III, a Director, purchased 800 shares at $15.15, adding to a modest recent accumulation pattern at FXNC—this represents his 6th purchase at this ticker within a 6-day window (2024-06-14 to 2024-06-20), totaling purchases of 800+ shares. The stock now trades at $14.91, down 4.5% over 30 days and 15.0% over 90 days from the transaction date, placing it 31.4% below its 52-week high of $21.75. His post-transaction holdings total 297,543 shares (297.5K shares), representing a 0.3% increase from the prior 296,743 shares (296.7K shares). The company shows solid fundamentals with a P/E of 10.43 and market cap of $93,595,631.43 ($93.6M), though annual revenue growth is modest at +1.7%. No prior timing outcomes are yet measurable for these recent June purchases, limiting ability to assess whether the clustering of buys during this period reflects favorable entry conditions.

medium
Buy
1,284 shares
$19,774
Significance 4/10

Director WILKINS III JAMES R purchased 1,284 shares of FXNC at $15.40 on 2024-06-18; stock now trading -31.8% from 52-week high at $14.83.

Director WILKINS III JAMES R purchased 1,284 shares at $15.40 on 2024-06-18, adding to a post-transaction holding of 296,743 shares. The transaction occurred in a deteriorating price environment: the stock trades at $14.83 (down 31.8% from its 52-week high of $21.75) and has declined 15.5% over the prior 90 days. The company shows modest fundamentals with 1.7% annual revenue growth, a P/E of 10.37, and a market cap of $93,093,441.59. Notably, this purchase is part of an intensive recent trading pattern: the director executed 5 separate purchases at FXNC between June 14 and June 20, 2024, all still outside measurable 90-day windows. While the director's broader cross-ticker track record includes 20 prior buy transactions, those prior trades lack quantified outcome data in FACTS. The cluster of purchases within a tight timeframe during a period of significant price deterioration warrants monitoring to assess whether this activity reflects a contrarian positioning or other motivations.

low
Buy
716 shares
$10,847
Significance 3/10

Director WILKINS III JAMES R bought 716 shares of FXNC at $15.15 on 2024-06-17; stock now -29.7% from 52-week high.

Director James R. Wilkins III purchased 716 shares at $15.15, adding 0.2% to his existing holdings of 294,743 shares. The purchase came as the stock trades 29.7% below its 52-week high of $21.75, and the company carries a modest valuation (P/E of 10.70) supported by recent profitability: $3.2M in net income on $2.5M quarterly revenue. Wilkins has a pattern of 5 prior trades at FXNC over a compressed timeframe (all within June 2024, including buys on 2024-06-14 and 2024-06-18), all below current levels. However, with outcomes on those trades not yet measurable and no measurable 90-day history available to assess timing patterns, the significance of this activity remains limited to a routine director accumulation without clear evidence of strategic conviction or contrarian insight.

medium
Buy
2,000 shares
$30,680
Significance 5/10

Director Wilkins III James R purchased 2,000 shares at $15.34 blended price on 2024-06-14; holdings now 294.7K shares. Stock down 10.6% in 90 days.

Director Wilkins III James R executed 4 separate purchases totaling 2,000 shares for $30,679.95 on 2024-06-14, increasing his position from 292.7K to 294.7K shares. The purchases occurred at prices ranging from $15.18 to $15.45, with a blended average of $15.34, while the stock currently trades at $15.51. His SAME-TICKER HISTORY at FXNC shows 5 prior buy transactions clustered around the same period (2024-06-11 through 2024-06-17), suggesting sustained acquisitions rather than a one-time event. The stock is trading 28.7% below its 52-week high of $21.75 and has declined 10.6% over the prior 90 days, placing this purchase in a period of price weakness relative to recent history.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access